KRAS and GNAS mutations were the most frequent mutations observed in our models, both being common mutations in PM-CRC and PMP, respectively [25,26], indicating that the PDX models are representative of the original disease and relevant models for investigating drug responses. Here, KRAS is linked to colorectal carcinoma.